Oral Oncology
Volume 46, Issue 1 , Pages 9-13 , January 2010

Oral cancer and polymorphism of ethanol metabolising genes

Received 5 August 2009 ,Revised 21 September 2009 ,Accepted 22 September 2009.

References 

  1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008;45(4–5):309–316
  2. Izarzugaza MI, Esparza H, Aguirre JM. Epidemiological aspects of oral and pharyngeal cancers in the Basque Country. J Oral Pathol Med. 2001;30(9):521–526
  3. Departamento de Sanidad Gobierno Vasco Eusko Jaurlaritza. Encuesta de Salud 2007; 2008. http://www.osasun.ejgv.euskadi.net/r52-publ01/es/contenidos/informacion/encuesta_salud_2007/es_es07/adjuntos/resultadosESCAV07.pdf.
  4. Wight AJ, Ogden GR. Possible mechanisms by which alcohol may influence the development of oral cancer – a review. Oral Oncol. 1998;34(6):441–447
  5. Peters ES, McClean MD, Liu M, Eisen EA, Mueller N, Kelsey KT. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev. 2005;14(2):476–482
  6. Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J, et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck. 2006;28(9):819–826
  7. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007;99(10):777–789
  8. Ho T, Wei Q, Sturgis EM. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck. 2007;29(7):682–699
  9. Petti S. Lifestyle risk factors for oral cancer. Oral Oncol. 2008;45(4–5):340–350
  10. Kabat GC, Wynder EL. Type of alcoholic beverage and oral cancer. Int J Cancer. 1989;43(2):190–194
  11. Jagerstad M, Skog K. Genotoxicity of heat-processed foods. Mutat Res. 2005;574(1–2):156–172
  12. Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer. 2000;87(5):734–740
  13. Visapaa JP, Gotte K, Benesova M, Li J, Homann N, Conradt C, et al. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde. Gut. 2004;53(6):871–876
  14. Berr C, Clavel-Chapelon F, Dally S et al. Alcohol health effects. INSERM 2001. http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/inserm2/Alcohol-health-effects_conversion.pdf.
  15. Jelski W, Szmitkowski M. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. Clin Chim Acta. 2008;395(1–2):1–5
  16. Olshan AF, Weissler MC, Watson MA, Bell DA. Risk of head and neck cancer and the alcohol dehydrogenase 3 genotype. Carcinogenesis. 2001;22(1):57–61
  17. Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, et al. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev. 2006;15(4):696–703
  18. Kuo PH, Kalsi G, Prescott CA, Hodgkinson CA, Goldman D, van den Oord EJ, et al. Association of ADH and ALDH genes with alcohol dependence in the Irish affected Sib Pair study of alcohol dependence (IASPSAD) sample. Alcohol Clin Exp Res. 2008;32(5):785–795
  19. Brennan P, Lewis S, Hashibe M, Bell DA, Boffetta P, Bouchardy C, et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol. 2004;159(1):1–16
  20. Asakage T, Yokoyama A, Haneda T, Yamazaki M, Muto M, Yokoyama T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis. 2007;28(4):865–874
  21. Duester G, Farres J, Felder MR, Holmes RS, Hoog JO, Pares X, et al. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochem Pharmacol. 1999;58(3):389–395
  22. Osier MV, Pakstis AJ, Soodyall H, Comas D, Goldman D, Odunsi A, et al. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet. 2002;71(1):84–99
  23. Holmes RS. Alcohol dehydrogenases: a family of isozymes with differential functions. Alcohol. 1994;(Suppl. 2):127–130
  24. Niederhut MS, Gibbons BJ, Perez-Miller S, Hurley TD. Three-dimensional structures of the three human class I alcohol dehydrogenases. Protein Sci. 2001;10(4):697–706
  25. Chen YC, Peng GS, Wang MF, Tsao TP, Yin SJ. Polymorphism of ethanol-metabolism genes and alcoholism: correlation of allelic variations with the pharmacokinetic and pharmacodynamic consequences. Chem Biol Interact. 2009;178(1–3):2–7
  26. Stone CL, Bosron WF, Dunn MF. Amino acid substitutions at position 47 of human beta 1 beta 1 and beta 2 beta 2 alcohol dehydrogenases affect hydride transfer and coenzyme dissociation rate constants. J Biol Chem. 1993;268(2):892–899
  27. Hoog JO, Svensson S. Mammalian class II alcohol dehydrogenase. A highly variable enzyme. Adv Exp Med Biol. 1997;414:303–311
  28. Li H, Mukherjee N, Soundararajan U, Tarnok Z, Barta C, Khaliq S, et al. Geographically separate increases in the frequency of the derived ADH1B*47His allele in eastern and western Asia. Am J Hum Genet. 2007;81(4):842–846
  29. Hashibe M, McKay JD, Curado MP, Oliveira JC, Koifman S, Koifman R, et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet. 2008;40(6):707–709
  30. Yokoyama A, Muramatsu T, Omori T, Yokoyama T, Matsushita S, Higuchi S, et al. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis. 2001;22(3):433–439
  31. Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology. 1986;6(3):502–510
  32. Coutelle C, Ward PJ, Fleury B, Quattrocchi P, Chambrin H, Iron A, et al. Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet. 1997;99(3):319–325
  33. Harty LC, Caporaso NE, Hayes RB, Winn DM, Bravo-Otero E, Blot WJ, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst. 1997;89(22):1698–1705
  34. Schwartz SM, Doody DR, Fitzgibbons ED, Ricks S, Porter PL, Chen C. Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase-3 genotypes. Cancer Epidemiol Biomarkers Prev. 2001;10(11):1137–1144
  35. Homann N. Alcohol and upper gastrointestinal tract cancer: the role of local acetaldehyde production. Addict Biol. 2001;6(4):309–323
  36. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem. 2000;267(14):4315–4324
  37. Visus C, Ito D, Amoscato A, Maciejewska-Franczak M, Abdelsalem A, Dhir R, et al. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res. 2007;67(21):10538–10545
  38. Spence JP, Liang T, Eriksson CJ, Taylor RE, Wall TL, Ehlers CL, et al. Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populations. Alcohol Clin Exp Res. 2003;27(9):1389–1394
  39. Simeone AM, Tari AM. How retinoids regulate breast cancer cell proliferation and apoptosis. Cell Mol Life Sci. 2004;61(12):1475–1484
  40. Lango M, Wentzel AL, Song JI, Xi S, Johnson DE, Lamph WW, et al. Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells. Clin Cancer Res. 2003;9(11):4205–4213
  41. Khuri FR, Lotan R, Kemp BL, Lippman SM, Wu H, Feng L, et al. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol. 2000;18(15):2798–2804
  42. Boccia S, Hashibe M, Galli P, De FE, Asakage T, Hashimoto T, et al. Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev. 2009;18(1):248–254
  43. Nomura T, Noma H, Shibahara T, Yokoyama A, Muramatusu T, Ohmori T. Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol. 2000;36(1):42–46
  44. Peterson RJ, Goldman D, Long JC. Nucleotide sequence diversity in non-coding regions of ALDH2 as revealed by restriction enzyme and SSCP analysis. Hum Genet. 1999;104(2):177–187
  45. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem. 1991;110(4):559–565
  46. Farin FM, Bigler LG, Oda D, McDougall JK, Omiecinski CJ. Expression of cytochrome P450 and microsomal epoxide hydrolase in cervical and oral epithelial cells immortalized by human papillomavirus type 16 E6/E7 genes. Carcinogenesis. 1995;16(6):1391–1401
  47. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P. Elucidation of CYP2E1 5′ regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol. 2001;37(5):437–445
  48. Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev. 1997;77(2):517–544
  49. Watanabe J, Hayashi S, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J Biochem. 1994;116(2):321–336
  50. Uematsu F, Ikawa S, Kikuchi H, Sagami I, Kanamaru R, Abe T, et al. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics. 1994;4(2):58–63
  51. Tsutsumi M, Takada A, Wang JS. Genetic polymorphisms of cytochrome P450 2E1 related to the development of alcoholic liver disease. Gastroenterology. 1994;107(5):1430–1435
  52. Morita S, Yano M, Tsujinaka T, Akiyama Y, Taniguchi M, Kaneko K, et al. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer. 1999;80(5):685–688
  53. Matthias C, Jahnke V, Jones PW, Hoban PR, Alldersea JE, Worrall SF, et al. Cyclin D1, glutathione S-transferase, and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomarkers Prev. 1999;8(9):815–823
  54. Li D, Dandara C, Parker MI. Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus. Clin Chem Lab Med. 2005;43(4):370–375
  55. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res. 2005;574(1–2):112–123
  56. Marques CF, Koifman S, Koifman RJ, Boffetta P, Brennan P, Hatagima A. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case–control study in Rio de Janeiro. Oral Oncol. 2006;42(6):632–637

PII: S1368-8375(09)00917-8

doi: 10.1016/j.oraloncology.2009.09.005

Oral Oncology
Volume 46, Issue 1 , Pages 9-13 , January 2010

Article Tools

* Image Usage & Resolution